Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis
- PMID: 34933963
- PMCID: PMC8693165
- DOI: 10.1136/openhrt-2021-001850
Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a well-established risk factor for cardiovascular disease, with ethnic and regional differences noted. With the recent surge of research within this field, we re-examine the evidence associating NAFLD with subclinical atherosclerosis, and investigate potential regional differences.
Methods: This is a systematic review and meta-analysis. PubMed and EMBASE were systematically searched for publications from January 1967 to July 2020 using standardised criteria. Original, observational studies investigating the association between NAFLD and either carotid intima-media thickness (CIMT) and/or coronary artery calcification (CAC) were included. Key outcomes included differences in mean CIMT, the presence of increased CIMT, the presence of CAC and the development/progression of CAC. Pooled ORs and pooled standard differences in means were calculated using random-effects models. Between-study heterogeneity was quantified using the Q statistic and I². Subgroup analyses stratified by region of study (Asian vs Western) were also conducted.
Results: 64 studies involving a total of 172 385 participants (67 404 with NAFLD) were included. 44 studies assessed the effect of NAFLD on CIMT, with the presence of NAFLD associated with increased CIMT (OR 2.00, 95% CI 1.56 to 2.56). 22 studies assessed the effects of NAFLD on CAC score, with the presence of NAFLD associated with the presence of any coronary calcification (OR 1.21, 95% CI 1.12 to 1.32), and the development/progression of CAC (OR 1.26, 95% CI 1.04 to 1.52). When stratified by region, these associations remained consistent across both Asian and Western populations (p>0.05). The majority (n=39) of studies were classified as 'high quality', with the remaining 25 of 'moderate quality'.
Conclusions: There is a significant positive association between various measures of subclinical atherosclerosis and NAFLD, seen across both Western and Asian populations. These results re-emphasise the importance of early risk evaluation and prophylactic intervention measures to preclude progression to clinical cardiovascular disease in patients with NAFLD.
Keywords: atherosclerosis; meta-analysis; metabolic syndrome.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures






Similar articles
-
Association of subclinical carotid artery atherosclerosis assessed by carotid ultrasound with nonalcoholic fatty liver disease fibrosis score in young and middle-aged men.Int J Cardiovasc Imaging. 2024 Sep;40(9):1979-1986. doi: 10.1007/s10554-024-03193-w. Epub 2024 Jul 16. Int J Cardiovasc Imaging. 2024. PMID: 39012403
-
Metabolic-associated fatty liver disease in relation to site-specific and multiple-site subclinical atherosclerosis.Liver Int. 2023 Aug;43(8):1691-1698. doi: 10.1111/liv.15591. Epub 2023 Jun 20. Liver Int. 2023. PMID: 37337780
-
Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.BMC Cardiovasc Disord. 2018 Jul 16;18(1):147. doi: 10.1186/s12872-018-0877-2. BMC Cardiovasc Disord. 2018. PMID: 30012085 Free PMC article.
-
Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.Rev Esp Enferm Dig. 2015 Jan;107(1):10-6. Rev Esp Enferm Dig. 2015. PMID: 25603326 Review.
-
Carotid Intima-Media Thickness in Indian Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and a Meta-Analysis.Cureus. 2024 Sep 2;16(9):e68439. doi: 10.7759/cureus.68439. eCollection 2024 Sep. Cureus. 2024. PMID: 39360047 Free PMC article. Review.
Cited by
-
Decoding the Liver-Heart Axis in Cardiometabolic Diseases.Circ Res. 2025 May 23;136(11):1335-1362. doi: 10.1161/CIRCRESAHA.125.325492. Epub 2025 May 22. Circ Res. 2025. PMID: 40403112 Free PMC article. Review.
-
Natural Sirtuin1 Activators and Atherosclerosis: an Overview.Curr Atheroscler Rep. 2023 Dec;25(12):979-994. doi: 10.1007/s11883-023-01165-4. Epub 2023 Dec 1. Curr Atheroscler Rep. 2023. PMID: 38038821 Free PMC article. Review.
-
Management of Cardiovascular Risk in the Non-alcoholic Fatty Liver Disease Setting.Eur Cardiol. 2024 May 9;19:e02. doi: 10.15420/ecr.2023.19. eCollection 2024. Eur Cardiol. 2024. PMID: 38807854 Free PMC article. Review.
-
Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment.Biomolecules. 2025 Feb 23;15(3):324. doi: 10.3390/biom15030324. Biomolecules. 2025. PMID: 40149860 Free PMC article. Review.
-
Machine learning identifies potential diagnostic biomarkers associated with ferroptosis in obstructive sleep apnea.Exp Ther Med. 2025 Mar 13;29(5):95. doi: 10.3892/etm.2025.12845. eCollection 2025 May. Exp Ther Med. 2025. PMID: 40162052 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical